Multiple Manufacturers



Multiple Manufacturers

Fluorouracil HCPCS:


HCPCS Code Descriptor:

Injection, fluorouracil, 500 mg


J Code

Fluorouracil NDCs:

16729-0276-67, 16729-0276-68, 70700-0187-23, 68001-0524-31, 63323-0117-20, 70700-0186-23, 68001-0524-30, 16729-0276-38, 70700-0189-22, 63323-0117-28, 25021-0215-99, 68001-0266-32, 68001-0525-32, 63323-0117-10, 70700-0188-22, 16729-0276-11, 63323-0117-61, 63323-0117-19, 63323-0117-18, 25021-0215-98, 68001-0525-27, 62332-0751-50, 63323-0117-68, 63323-0117-69, 63323-0117-51, 63323-0117-58, 63323-0117-59

Primary Type:


Generic/Specialty Status:


Route of Administration:


Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Fluorouracil:

FLUOROURACIL is an Oncology drug manufactured by Fresenius Kabi and administered via the Intravenous route of administration. The J Code: J9190 is aligned to the drug FLUOROURACIL.

Fluorouracil is a type of chemotherapy drug that belongs to a group of medicines called anti metabolites. Fluorouracil may be used to treat a variety of different types of cancers, such as colon, rectum, breast, stomach, or pancreas cancer. Fluorouracil and other anti-metabolites are thought to work by stopping cancer cells from making and repairing DNA, which in turn stops their growth and multiplication. Fluorouracil is often given in combination with other forms of chemotherapy.


J9190 Added Date:

January 1, 1984

J9190 Effective Date:

January 1, 2009

J9190 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Fluorouracil billing and coding information.
Fluorouracil patient assistance information can be found through Bausch Health’s Patient Assistance Program at the URL:
FLUOROURACIL prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for FLUOROURACIL. Please check back in a few weeks.